CBI’s Strategic Medicare Contracting Forum for Bio/Pharmaceutical Manufacturers

CBI’s Strategic Medicare Contracting Forum for Bio/Pharmaceutical Manufacturers
June 19-20, 2019 | Alexandria, VA
www.cbinet.com/Medicare

CBI’s Strategic Medicare Contracting Forum for Bio/Pharma Manufacturers provides a real-time analysis of newly proposed regulations, including the proposal to eliminate rebates, the use of step therapy under Medicare Part B, changes to coverage gap, influence of the International Pricing Index and much more.

Exclusive Offer for Drug Channels Readers:
Register Now and SAVE $400* using promo code MED400.

Taking place June 19-20 in Alexandria, VA, we invite you to convene with fellow stakeholders to receive an in-depth look into legislative and regulatory changes to Medicare and how it will impact manufacturers. You and your team members will benefit from this opportunity by gaining insights from industry experts on the complex changes occurring within Medicare, walking away with critical perspectives and robust knowledge on key topics.

Hear from 20+ Key Experts on High-Impact Issues, including:

• [Keynote Address] Washington Update on Medicare Policy — The White House
• HHS Keynote Address — U.S. Department of Health and Human Services (invited)
• International Pricing Index Model: Evaluate the Proposed Changes for Medicare Part B Drugs — American Action Forum and Pacific Research
• Examine the Implementation Strategies for Step Therapy Under Medicare Part B — BIO and Bristol-Myers Squibb
• [Panel Discussion] Discover Coverage and Payment Strategies for Novel and High Cost Therapies for Rare Diseases Under Medicare Parts A and B — Health Policy Strategies, Inc., King & Spalding and Gilead Sciences
• Impact of Value Frameworks on Access to Medications — Pfizer Inc.
• What’s Next for Medicare? — Perspective From Capitol Hill — U.S. House of Representatives

Visit www.cbinet.com/Medicare to view the complete speaker and in-depth session lineup, then register using promo code MED400 for this exclusive savings of $400 off!

*Discount expires 6/18/19; cannot be combined or applied to existing registration. Other restrictions may apply.

---

The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.